Zydus Cadila obtains FDA green light for generic K-Dur

Patients who need to treat or prevent low amounts of potassium in the blood will soon have a new generic mineral supplement available.

The Food and Drug Administration has given Zydus Cadila the go ahead for potassium chloride ER tablets in dosage strengths of 10 mEq (750 mg) and 20 mEq (1500 mg). The product is the generic of Merck Sharp and Dohme’s K-Dur.

The generic will be manufactured at Zydus Cadila's formulation manufacturing facility in SEZ, Ahmedabad.